CLINICAL_TRIALS
trial_result
· 2013-05-24
Clinical Trial Update: A Feasibility Study of Adaptive Intensity-Modulated Radiation Therapy [EARLY_Phase 1]
Summary
A feasibility study in early Phase 1 evaluating adaptive intensity-modulated radiation therapy for head and neck cancer has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Washington University School of Medicine | Conditions: Head and Neck Cancer | EARLY_Phase 1 | Status: TERMINATED